FrancophonIA/ELRC3.0 huggingface dataset:
English: Due to the potential risk of toxicity from the high propylene glycol content of Agenerase oral solution, this formulation is contraindicated in children below the age of four years and should be used with caution in certain other patient populations.
Latvian: Bērniem, kuri jaunāki par 4 gadiem, ir kontrindicēta Agenerase perorālā šķīduma lietošana, bet atsevišķām citām pacientu grupām, lietojot šķīdumu, ir jāievēro piesardzība, jo tajā ir augsta propilēnglikola koncentrācija, kas var radīt iespējamu toksisku iedarbību.
English: MARKETING AUTHORISATION NUMBER EU/1/00/148/004
Latvian: 12. REĢISTRĀCIJAS NUMURS(I) EU/1/00/148/004
English: Lipid disorders should be managed as clinically appropriate (see section 4.8).
Latvian: Lipīdu maiņas traucējumi jāārstē klīniski piemērotā veidā.
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states (EU/EEA)
Latvian: Zāļu nosaukumu, zāļu formu, stiprumu, lietošanas veidu, reģistrācijas apliecības īpašnieku saraksts dalībvalstīs (ES/EEZ)
English: GEROLYMATOS ΑΕΒΕ 13 Asklipiou Str.
Latvian: P.N.G. GEROLYMATOS ΑΕΒΕ 13 Asklipiou Str.
English: S.A.Pº de Las Doce Estrellas, 5 - 7 28042 MADRID
Latvian: Pº de Las Doce Estrellas, 5 - 7 28042 MADRID
English: Capsule
Latvian: Kapsulas
English: m .
Latvian: C.
English: CZ - Czech Republic
Latvian: CZ - Čehijas Republika
English: LV - Latvia
Latvian: LV - Latvija
English: HU - Hungary
Latvian: HU - Hungārija
English: NO - Norway
Latvian: NO - Norvēģija
English: RO - Romania
Latvian: RO - Rumānija
English: PT - Portugal
Latvian: PT - Portugāle
English: IS - Iceland
Latvian: IS - Islande
English: BG - Bulgaria
Latvian: BG - Bulgārija
English: Janssen-Cilag A/S (TIBOTEC) Hammerbakken 19
Latvian: Janssen-Cilag A/S (TIBOTEC)
English: LT - Lithuania
Latvian: LT - Lietuva
English: Mundipharma AB Mölndalsvägen 30 B 412 63 Göteborg Sweden
Latvian: Mundipharma AB Mölndalsvägen 30 B 412
English: C. F. Tietgens Boulevard 40 5220 ODENSE SØ Denmark
Latvian: F. Tietgens Boulevard 40 5220 ODENSE SØ Denmark
English: EL-Greece
Latvian: EL - Grieķija
English: DOCPHARMA N.V. Ambachtenlaan 13H 3001 Leuven Belgium
Latvian: Ambachtenlaan 13H 3001 Leuven Belgium
English: S.p.A. Viale Amelia 70 00181 Roma Italy
Latvian: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Viale Amelia 70 00181 Roma Italy
English: C.F. Tietgens Boulevard 40 DK-5220 Odense SØ Danmark
Latvian: Tietgens Boulevard 40 DK-5220 Odense SØ Danmark
English: AT - Austria betapharm Arzneimittel GmbH Kobelweg 95
Latvian: AT - Austrija betapharm Arzneimittel GmbH Kobelweg 95
English: Controlled release granules for oral suspension
Latvian: Kontrolētas atbrīvošanās granulas iekšķīgi lietojamas suspensijas pagatavošanai
English: SI - Slovenia
Latvian: SI - Slovēnija
English: GlaxoSmithKline B.V. Huis ter Heideweg 62 NL-3705 LZ Zeist The Netherlands
Latvian: Huis ter Heideweg 62 NL-3705 LZ Zeist The Netherlands
English: Mundipharma Pharmaceuticals Srl Via G. Serbelloni, 4
Latvian: Mundipharma Pharmaceuticals Srl Via G.
English: Ratiopharm Nederland B.V. Ronde Tocht 11
Latvian: Ratiopharm Nederland B.V.
English: LULuxembourg
Latvian: LULuksemburga
English: SK - Slovakia
Latvian: SK - Slovākijas Republika
English: Prolonged release capsule
Latvian: Ilgstošās darbības kapsulas
English: LAVIPHARM HELLAS AE Agias Marinas Str. Paiania Attikis 19002 Greece
Latvian: LAVIPHARM HELLAS AE Agias Marinas Str.
English: GLAXOSMITHKLINE S.A. Rue Du Tilleul 13
Latvian: Rue Du Tilleul 13
English: BE - Belgium
Latvian: BE - Beļģija
English: 200 mg coated tablet
Latvian: 200 mg Apvalkotā tablete
English: Apollogasse 16-18, Postfach 83 1072 Vienna
Latvian: Mundipharma Ges.m.b.H. Apollogasse 16-18, Postfach 83 1072 Vienna
English: Ethypharm21, rue St. Mathieu (Z.I.)
Latvian: Ethypharm21, rue St. Mathieu (Z.I.) F- 78550 Houdan
English: 17-21, rue St. Mathieu (Z.I.)
Latvian: 17-21, rue St. Mathieu (Z.I.) F- 78550 Houdan
English: Prolonged-release micropillules in hard capsule
Latvian: Ilgstošas darbības mikropilules cietā kapsulā
English: Targinact 20 mg/ 10 mg, tabletten met verlengde afgifte 20 and 10 mg Prolonged release tablet
Latvian: Targinact 20 mg/ 10 mg, tabletten met verlengde afgifte 20 and 10 mg Ilgstošās darbības tablete
English: 100 mg Prolonged-release tablet betapharm Arzneimittel GmbH Kobelweg 95
Latvian: 100 mg Ilgstošās darbības tablete betapharm Arzneimittel GmbH Kobelweg 95
English: NL-3705 LZ Zeist
Latvian: Huis ter Heideweg 62 NL-3705 LZ Zeist
English: Targinact 10 mg/ 5 mg, tabletten met verlengde afgifte 10 and 5 mg Prolonged release tablet
Latvian: Targinact 10 mg/ 5 mg, tabletten met verlengde afgifte 10 and 5 mg Ilgstošās darbības tablete
English: 100 mg Prolonged-release micropillules in hard capsule
Latvian: 100 mg Ilgstošas darbības mikropilules cietā kapsulā
English: MSTW 200 mg Krugmann 200 mg Prolonged-release tablet
Latvian: MSTW 200 mg Krugmann 200 mg Ilgstošās darbības tablete
English: SUBSTITOL 200 mg trde kapsule s podaljšanim sproščanjem200 mg Prolonged-release capsule, hard Oral use
Latvian: SUBSTITOL 200 mg trde kapsule s podaljšanim sproščanjem200 mg Ilgstošās darbības cietās kapsulas
English: MORFINA LANNACHER 100 MG 100mg coated tablet
Latvian: MORFINA LANNACHER 100 MG 100mg
English: Morphin Grünenthal 100 mg 100 mg Prolonged-release tablet
Latvian: Morphin Grünenthal 100 mg 100 mg Ilgstošās darbības tablete
English: Morphinhydrochlorid Lannacher retard 200 mg - Filmtabletten 200 mg Prolonged-release tablet
Latvian: Morphinhydrochlorid Lannacher retard 200 mg - Filmtabletten 200 mg Ilgstošās darbības tablete
English: PS Pharma Service GmbH Lise-Meitner-Str. 10 D-40670 Meerbusch Germany
Latvian: PS Pharma Service GmbH Lise-Meitner-Str.
English: Morphin AWD 100 mg retard 100 mg Prolonged-release tablet
Latvian: Morphin AWD 100 mg retard 100 mg Ilgstošās darbības tablete
English: Kapanol 100, capsules met gereguleerde afgifte 20 mg 100 mg Prolonged-release capsule Oral use
Latvian: Kapanol 100, capsules met gereguleerde afgifte 20 mg 100 mg Ilgstošās darbības kapsulas
English: Mundipharma Pharmaceuticals B.V. De Weil 20
Latvian: Mundipharma Pharmaceuticals B.V.
English: MSTW 100 mg Krugmann 100 mg Prolonged-release tablet
Latvian: MSTW 100 mg Krugmann 100 mg Ilgstošās darbības tablete
English: Prolonged-release granules for oral suspension
Latvian: Ilgstošas darbības granulas iekšķīgi lietojamas suspensijas pagatavošanai
English: Morphin 100 retard Heumann 100 mg Prolonged-release tablet
Latvian: Morphin 100 retard Heumann 100 mg Ilgstošās darbības tablete
English: SE - Sweden ratiopharm GmbH Graf-Arco-Strasse 3 DE-89079 Ulm Germany
Latvian: SE - Zviedrija ratiopharm GmbH Graf-Arco-Strasse 3 DE-89079 Ulm Germany
English: FILNARINE SR 200MG PROLONGED RELEASE TABLETS 200 mg Prolonged-release tablet
Latvian: FILNARINE SR 200MG PROLONGED RELEASE TABLETS 200 mg Ilgstošās darbības tablete
English: Apollogasse 16-18., A-1072 Vienna Austria
Latvian: Mundipharma Ges.m.b.H. Apollogasse 16-18., A-1072 Vienna Austria
English: Via delle Ande, 15
Latvian: BRUNO FARMACEUTICI S.P.A. Via delle Ande, 15
English: P.N.G.
Latvian: C.F.
English: Schlossplatz 1 8502 Lannach Austria
Latvian: FI - Somija Schlossplatz 1 8502 Lannach
English: FI - Finland ratiopharm GmbH Graf-Arco-Strasse 3 89079 ULM Germany
Latvian: FI - Somija ratiopharm GmbH Graf-Arco-Strasse 3 89079 ULM Germany
English: Morphin ZWEI PS Pharma 60 mg retard ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Morphin ZWEI PS Pharma 60 mg retard ratiopharm GmbH Graf-Arco-Str.
English: GlaxoSmithKline GmbH & Co. KG Theresienhöhe 11
Latvian: GlaxoSmithKline GmbH & Co.
English: MORFINA LANNACHER 10 MG 10 mg coated tablet
Latvian: MORFINA LANNACHER 10 MG 10 mg
English: Modified-release capsule
Latvian: Cietās kapsulas
English: MORFINA LANNACHER 30 MG 30 mg coated tablet
Latvian: MORFINA LANNACHER 30 MG 30 mg
English: MORFINA LANNACHER 60 MG 60 mg coated tablet
Latvian: MORFINA LANNACHER 60 MG 60 mg
English: Relimal 200 mg Retardtabletten 200 mg Prolonged-release tablet
Latvian: Relimal 200 mg Retardtabletten 200 mg Ilgstošās darbības tablete
English: MST 100 mg Mundipharma 100 mg Prolonged-release tablet
Latvian: MST 100 mg Mundipharma 100 mg Ilgstošās darbības tablete
English: 18 mg + 9 mg Prolonged-release tablet
Latvian: 18 mg + 9 mg Ilgstošās darbības tablete
English: MST 200 mg Mundipharma 200 mg Prolonged-release tablet
Latvian: MST 200 mg Mundipharma 200 mg Ilgstošās darbības tablete
English: AWD.pharma GmbH & Co. KG Wasastr.
Latvian: AWD.pharma GmbH & Co.
English: 13 D-24941 Flensburg Germany
Latvian: Juta Pharma GmbH Gutenbergstr. 13 D-24941 Flensburg Germany
English: Oxycodonhydrochloridratiopharm 5 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodonhydrochloridratiopharm 5 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: Oxycodonhydrochloridratiopharm 20 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodonhydrochloridratiopharm 20 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: Oxycodon-HCl-ratiopharm 80 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodon-HCl-ratiopharm 80 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: Hydromorphon-ratiopharm 8 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Hydromorphon-ratiopharm 8 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: Oxycodon-HCl-ratiopharm 20 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodon-HCl-ratiopharm 20 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: TARGINACT 5MG/2,5MG 5.25 mg Prolonged-release tablet
Latvian: TARGINACT 5MG/2,5MG 5.25 mg Ilgstošās darbības tablete
English: Hydromorphon-ratiopharm 24 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Hydromorphon-ratiopharm 24 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: Oxycodonhydrochloridratiopharm 40 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodonhydrochloridratiopharm 40 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: MST Continus 100 mg filmsko obložene tablete s podaljšanim sproščanjem film-coated prolonged-release capsule, hard
Latvian: MST Continus 100 mg filmsko obložene tablete s podaljšanim sproščanjem
English: MST CONTINUS 100 MG PROLONGED-RELEASE TABLETS 100 mg Prolonged-release tablet
Latvian: MST CONTINUS 100 MG PROLONGED-RELEASE TABLETS 100 mg Ilgstošās darbības tablete
English: MST Continus 30 mg filmsko obložene tablete s podaljšanim sproščanjem film-coated prolonged-release capsule, hard
Latvian: MST Continus 30 mg filmsko obložene tablete s podaljšanim sproščanjem
English: Oxycodonhydrochloridratiopharm 10 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodonhydrochloridratiopharm 10 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: Oxycodon-HCl-ratiopharm 5 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodon-HCl-ratiopharm 5 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: A-1072 Viena
Latvian: A-1072
English: 100 mg Prolonged-release capsule, hard Oral use medac Gesellschaft für klinische Spezialpräparate mbH Fehlandtstr.
Latvian: 100 mg Ilgstošās darbības cietās kapsulas medac Gesellschaft für klinische Spezialpräparate mbH Fehlandtstr. 3
English: Hydromorphon-ratiopharm 4 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Hydromorphon-ratiopharm 4 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: MST Continus 10 mg filmsko obložene tablete s podaljšanim sproščanjem film-coated prolonged-release capsule, hard
Latvian: MST Continus 10 mg filmsko obložene tablete s podaljšanim sproščanjem
English: 2000 mg Modified-release tablet
Latvian: 2000 mg Ilgstošās darbības tablete
English: Oxycodon-HCl-ratiopharm 10 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Latvian: Oxycodon-HCl-ratiopharm 10 mg Retardtabletten ratiopharm GmbH Graf-Arco-Str.
English: • The maximum dose should not exceed 2 g per day.
Latvian: • Maksimālā deva nedrīkst pārsniegt 2 g dienā.
English: Vancomycin capsules
Latvian: Vankomicīna kapsulas
English: More about the procedure
Latvian: Papildinformācija par procedūru
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom21 September 2017 EMA/645879/2017
Latvian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom2017. gada 21. septembris EMA/645879/2017
English: The CHMP opinion was forwarded to the European Commission, which issued a final legally binding decision applicable in all EU Member States on 21/09/2017.
Latvian: CHMP atzinums tika nosūtīts Eiropas Komisijai, kura 2017. gada 21. septembrī izdeva visās ES dalībvalstīs juridiski saistošu galīgo lēmumu.
English: • Patients who have any questions about their treatment should talk to their doctor or pharmacist.
Latvian: • Ja pacientiem ir kādi jautājumi par viņiem veikto ārstēšanu, tie jāuzdod ārstam vai farmaceitam.
English: The review of vancomycin-containing medicines was initiated on 1 April 2016 at the request of the Spanish medicines agency (AEMPS), under Article 31 of Directive 2001/83/EC.
Latvian: Vankomicīnu saturošu zāļu pārskatīšana tika uzsākta 2016. gada 1. aprīlī pēc Spānijas Zāļu aģentūras (AEMPS) pieprasījuma saskaņā ar Direktīvas 2001/83/EK 31. pantu.
English: The review was carried out by the Committee for Medicinal Products for Human Use (CHMP), responsible for questions concerning medicines for human use, which adopted the Agency's opinion.
Latvian: Pārskatīšanu veica Cilvēkiem paredzēto zāļu komiteja (CHMP), kas ir atbildīga par jautājumiem saistībā ar cilvēkiem paredzētām zālēm un kas pieņēma Aģentūras atzinumu.
English: For younger children, the use of age-appropriate formulations is recommended.
Latvian: Jaunākiem bērniem ieteicams lietot viņu vecumam piemērotus preparātus.
English: Therefore, oral vancomycin should no longer be used in these indications.
Latvian: Tāpēc iekšķīgi lietojamos vankomicīna preparātus vairs nevajadzētu izmantot šīm indikācijām.
English: Vancomycin-containing medicines have been authorised nationally in the EU for many years, as Vancocin and a variety of other names.
Latvian: Vankomicīnu saturošas zāles jau daudzus gadus ir reģistrētas ES nacionālo procedūru veidā ar nosaukumu Vancocin un daudziem citiem nosaukumiem.
English: • The available information on vancomycin has been reviewed and recommendations have been made on its safe use and appropriate dosage.
Latvian: • Tika pārskatīta pieejamā informācija par vankomicīnu un sagatavoti ieteikumi par tā drošu lietošanu un atbilstošajām devām.
English: In addition, the Committee reviewed the recommended dosage for vancomycin for the various indications and patient groups, and concluded that the starting dose of vancomycin by infusion should be calculated according to the age and weight of the patient.
Latvian: Turklāt komiteja pārskatīja ieteicamās vankomicīna devas dažādām indikācijām un pacientu grupām un secināja, ka vankomicīna infūzijas sākumdeva ir jāaprēķina pēc pacienta vecuma un ķermeņa masas.
English: Information for healthcare professionals The Agency's recommendations are based on a review of the available pharmacological and clinical data for vancomycin.
Latvian: Aģentūras ieteikumi ir balstīti uz pieejamo vankomicīna farmakoloģisko un klīnisko datu izvērtējumu.
English: • Any subsequent dose adjustments should be based on serum concentrations to achieve the target therapeutic concentrations.
Latvian: • Jebkādi turpmāki devu pielāgojumi jānosaka pēc koncentrācijas serumā, lai sasniegtu ārstniecisko mērķa koncentrāciju.
English: • The product information for medicines containing vancomycin will be updated to take these recommendations into account.
Latvian: • Vankomicīnu saturošo zāļu informācija tiks atjaunināta saskaņā ar šiem ieteikumiem.
English: The updated recommendations are based on data which showed that the previously recommended dose often resulted in less than optimal levels of vancomycin in the blood, reducing the effectiveness of the antibiotic.
Latvian: Atjaunināto ieteikumu pamatā ir dati, kas liecina, ka iepriekš ieteiktā deva radīja nepietiekami optimālu vankomicīna līmeni asinīs, tādējādi samazinot šo antibiotiku efektivitāti.
English: More about the medicine
Latvian: Papildinformācija par zālēm
English: Available data showed that the previously recommended daily dose often resulted in suboptimal vancomycin serum concentrations.
Latvian: Pieejamie dati liecina, ka iepriekš ieteiktā dienas deva bieži vien uzrādīja nepietiekami optimālu vankomicīna koncentrāciju serumā.
English: Because the available data do not adequately support the use of vancomycin in the treatment of staphylococcal enterocolitis (inflammation of the gut caused by S. aureus) and its use to clear the gut of bacteria in patients with a weakened immune (defence) system, the CHMP concluded that vancomycin should no longer be used for these indications.
Latvian: Tā kā pieejamie dati nepietiekami pamato vankomicīna lietošanu stafilokoku izraisīta enterokolīta (S. aureus izraisīta zarnu iekaisuma) ārstēšanā un nolūkā attīrīt zarnas no baktērijām pacientiem ar novājinātu imūnsistēmu (organisma dabisko aizsargsistēmu), CHMP secināja, ka vankomicīnu vairs nevajadzētu lietot šīm indikācijām.
English: • Vancomycin capsules can be used in patients aged 12 years and older for the treatment of CDI.
Latvian: • Vankomicīna kapsulas var lietot pacientiem no 12 gadu vecuma, lai ārstētu CDI.
English: • Vancomycin solution for infusion can be used in patients of all ages for the treatment of complicated soft-tissue infections, bone and joint infections, community- and hospital-acquired pneumonia (including ventilator-associated pneumonia), infective endocarditis, acute bacterial meningitis, and bacteraemia associated with the above infections.
Latvian: • Vankomicīna šķīdumu infūzijām var lietot visu vecumu pacientiem, lai ārstētu komplicētas mīksto audu infekcijas, kaulu un locītavu infekcijas, sadzīvē iegūtu un stacionārā iegūtu pneimoniju (tostarp ar plaušu mākslīgo ventilāciju saistītu pneimoniju), infekciozu endokardītu, akūtu bakteriālu meningītu un ar minētajām infekcijām saistītu bakteriēmiju.
English: It can also be taken by mouth (as capsules or liquid) to treat an infection of the lining of the gut caused by bacteria called Clostridium difficile.
Latvian: To var lietot arī iekšķīgi (kā kapsulas vai šķidrumu), lai ārstētu zarnu iekšējo sieniņu infekciju, ko izraisījusi baktērija Clostridium difficile.
English: Vancomycin is one of a group of antibiotics known as glycopeptides.
Latvian: Vankomicīns pieder pie antibiotiku grupas glikopeptīdiem.
English: • Vancomycin is an antibiotic used for serious infections, often caused by bacteria that have become resistant to other treatments.
Latvian: • Vankomicīns ir antibiotika, ko lieto, lai ārstētu nopietnas infekcijas, kuras bieži ir izraisījušas baktērijas, kas kļuvušas rezistentas jeb noturīgas pret citiem ārstēšanas līdzekļiem.
English: The CHMP concluded that infusion of vancomycin can continue to be used for the treatment of serious infections caused by certain bacteria including MRSA (meticillin-resistant Staphylococcus aureus) in patients of all ages.
Latvian: CHMP secināja, ka vankomicīna infūziju var lietot arī turpmāk, lai visu vecumu pacientiem ārstētu nopietnas infekcijas, ko izraisījušas noteiktas baktērijas, tostarp MRSA (pret meticilīnu rezistents Staphylococcus aureus).
English: Vancomycin is also given by mouth to treat infections caused by Clostridium difficile, which mostly develop in hospital patients treated with other antibiotics.
Latvian: Vankomicīnu lieto arī iekšķīgi, lai ārstētu Clostridium difficile izraisītas infekcijas, kas lielākoties rodas stacionārā ar citām antibiotikām ārstētiem pacientiem.
English: It is given by infusion (drip) into a vein to treat serious infections due to Gram-positive bacteria such as meticillin-resistant Staphylococcus aureus (MRSA) that are resistant to other antibiotics, or in patients in whom other antibiotics cannot be used.
Latvian: Šīs zāles ievada ar infūziju (pa pilienam) vēnā, lai ārstētu nopietnas infekcijas, ko izraisījušas tādas grampozitīvās baktērijas kā pret meticilīnu rezistents Staphylococcus aureus (MRSA), kas ir noturīgas pret citām antibiotikām, vai lai ārstētu pacientus, kuri nevar lietot citas antibiotikas.
English: On 19 May 2017, the European Medicines Agency (EMA) recommended changes to prescribing information for the antibiotic vancomycin to ensure appropriate use in the treatment of serious infections caused by Gram-positive bacteria.
Latvian: Izmaiņu mērķis ir nodrošināt pareizu antibiotiku lietošanu, lai apkarotu rezistenci pret antimikrobiālajiem līdzekļiem2017. gada 19. maijā Eiropas Zāļu aģentūra (EMA) ieteica mainīt informāciju par vankomicīna antibiotiku parakstīšanu, lai nodrošinātu to pareizu lietošanu grampozitīvo baktēriju izraisītu nopietnu infekciju ārstēšanā.
English: Vancomycin can also be used to prevent bacterial endocarditis (an infection in the heart) in patients undergoing surgery and to treat infections in patients undergoing a procedure called peritoneal dialysis.
Latvian: Vankomicīnu var arī lietot, lai novērstu bakteriālo endokardītu (sirds infekciju) pacientiem, kuriem tiek veikta operācija, un lai ārstētu infekcijas pacientiem, kuriem veic procedūru, ko sauc par peritoneālo dialīzi.
English: • In patients with inflammatory intestinal disorders, the serum concentration of vancomycin after oral administration should be closely monitored.
Latvian: • Pacientiem ar iekaisīgiem zarnu traucējumiem ir rūpīgi jāuzrauga vankomicīna koncentrācija serumā pēc šo zāļu iekšķīgas lietošanas.
English: It can also be used for perioperative prophylaxis in patients at risk of developing bacterial endocarditis and for the treatment of peritoneal dialysis-associated peritonitis.
Latvian: To var arī lietot kā perioperatīvu profilaksi pacientiem, kuriem ir bakteriālā endokardīta veidošanās risks, un ar peritoneālo dialīzi saistīta peritonīta ārstēšanai.
English: • Vancomycin parenteral formulations authorised for intraperitoneal use can be used in patients of all ages for the treatment of peritoneal dialysis-associated peritonitis.
Latvian: • Vankomicīna parenterālos preparātus, kas reģistrēti intraperitoneālai lietošanai, var lietot visu vecumu pacientiem, lai ārstētu ar peritoneālo dialīzi saistītu peritonītu.
English: • The available data do not adequately support the use of oral vancomycin in the treatment of staphylococcal enterocolitis and for the decontamination of the GI tract in immunocompromised patients.
Latvian: • Pieejamie dati pietiekami nepamato iekšķīgi lietojamo vankomicīna preparātu izmantošanu stafilokoku izraisīta enterokolīta ārstēšanai un kuņģa-zarnu trakta attīrīšanai pacientiem ar novājinātu imunitāti.
English: • Vancomycin parenteral formulations authorised for oral use can be used by mouth in patients of all ages for the treatment of Clostridium difficile infection (CDI).
Latvian: • Vankomicīna parenterālos preparātus, kas reģistrēti iekšķīgai lietošanai, visu vecumu pacienti var lietot iekšķīgi caur muti, lai ārstētu Clostridium difficile infekciju (CDI).
English: When taken by mouth, use should be limited to the treatment of Clostridium difficile infections (CDI).
Latvian: Iekšķīgi jeb caur muti lietojamos vankomicīna preparātus vajadzētu izmantot tikai Clostridium difficile infekciju (CDI) ārstēšanai.
English: • The recommended starting dose of vancomycin solution for infusion should be based on the age and weight of the patient.
Latvian: • Vankomicīna šķīduma infūzijām ieteicamā sākumdeva ir atkarīga no pacienta vecuma un ķermeņa masas.
English: It is given as an infusion (drip) into a vein or by injection in the abdomen (belly).
Latvian: Vankomicīnu ievada infūzijas veidā (pa pilienam) vēnā vai injekcijas veidā vēderā.
English: The product information for vancomycin will be updated to reflect the following: Vancomycin solution for infusion
Latvian: Vankomicīna zāļu apraksts tiks atjaunināts, lai atspoguļotu turpmāk tekstā norādītos datus.